About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
GLP-1s have exploded in popularity, to the where, a ccording to the Kaiser Family Foundation, 12% of adults has taken Ozempic ...
Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications ...
"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. She said these cost-of-care conversations are now a daily occurrence. While glucagon-like ...
More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows–raising questions ...
A NEW weight loss drug could hijack the brain like a ‘Trojan horse’ to double weight loss. The drug could help the body to ...
GLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and pricing. CMS has taken steps ...
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs for weight loss.